Invesco’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $568M | Sell |
9,051,941
-4,266,236
| -32% | -$341M | 0.06% | 300 |
|
|
2025
Q4 | $1.27B | Sell |
13,318,177
-3,645,167
| -21% | -$357M | 0.12% | 139 |
|
|
2025
Q3 | $1.66B | Buy |
16,963,344
+111,826
| +0.7% | +$11.6M | 0.26% | 53 |
|
|
2025
Q2 | $1.81B | Buy |
16,851,518
+226,578
| +1% | +$22.9M | 0.31% | 38 |
|
|
2025
Q1 | $1.68B | Buy |
16,624,940
+834,274
| +5% | +$84M | 0.32% | 38 |
|
|
2024
Q4 | $1.41B | Buy |
15,790,666
+1,893,012
| +14% | +$167M | 0.26% | 55 |
|
|
2024
Q3 | $1.16B | Buy |
13,897,654
+1,211,748
| +10% | +$95.5M | 0.22% | 75 |
|
|
2024
Q2 | $977M | Buy |
12,685,906
+84,708
| +0.7% | +$6.2M | 0.21% | 86 |
|
|
2024
Q1 | $863M | Buy |
12,601,198
+53,419
| +0.4% | +$3.43M | 0.19% | 104 |
|
|
2023
Q4 | $725M | Sell |
12,547,779
-2,314,239
| -16% | -$124M | 0.17% | 118 |
|
|
2023
Q3 | $785M | Buy |
14,862,018
+211,732
| +1% | +$11.1M | 0.21% | 87 |
|
|
2023
Q2 | $792M | Buy |
14,650,286
+5,465,411
| +60% | +$285M | 0.21% | 94 |
|
|
2023
Q1 | $460M | Buy |
9,184,875
+3,245,517
| +55% | +$153M | 0.13% | 188 |
|
|
2022
Q4 | $275M | Buy |
5,939,358
+457,629
| +8% | +$19.8M | 0.08% | 343 |
|
|
2022
Q3 | $212M | Sell |
5,481,729
-502,112
| -8% | -$20.1M | 0.07% | 394 |
|
|
2022
Q2 | $223M | Sell |
5,983,841
-800,792
| -12% | -$32.6M | 0.07% | 398 |
|
|
2022
Q1 | $300M | Sell |
6,784,633
-623,532
| -8% | -$27M | 0.08% | 352 |
|
|
2021
Q4 | $315M | Buy |
7,408,165
+232,665
| +3% | +$9.78M | 0.08% | 345 |
|
|
2021
Q3 | $311M | Sell |
7,175,500
-105,532
| -1% | -$4.67M | 0.08% | 319 |
|
|
2021
Q2 | $311M | Buy |
7,281,032
+125,890
| +2% | +$5.3M | 0.08% | 327 |
|
|
2021
Q1 | $277M | Buy |
7,155,142
+92,650
| +1% | +$3.51M | 0.07% | 339 |
|
|
2020
Q4 | $254M | Sell |
7,062,492
-557,208
| -7% | -$20.1M | 0.07% | 345 |
|
|
2020
Q3 | $291M | Sell |
7,619,700
-1,581,138
| -17% | -$60.9M | 0.1% | 241 |
|
|
2020
Q2 | $323M | Sell |
9,200,838
-962,672
| -9% | -$34.7M | 0.12% | 208 |
|
|
2020
Q1 | $332M | Sell |
10,163,510
-1,780,425
| -15% | -$69.6M | 0.14% | 171 |
|
|
2019
Q4 | $540M | Sell |
11,943,935
-1,269,973
| -10% | -$53.1M | 0.17% | 135 |
|
|
2019
Q3 | $538M | Buy |
13,213,908
+893,519
| +7% | +$37.9M | 0.14% | 157 |
|
|
2019
Q2 | $530M | Buy |
12,320,389
+3,714,624
| +43% | +$143M | 0.14% | 162 |
|
|
2019
Q1 | $330M | Sell |
8,605,765
-1,254,781
| -13% | -$47.9M | 0.11% | 209 |
|
|
2018
Q4 | $348M | Buy |
9,860,546
+344,325
| +4% | +$12.5M | 0.13% | 169 |
|
|
2018
Q3 | $366M | Buy |
9,516,221
+1,238,574
| +15% | +$43.3M | 0.12% | 188 |
|
|
2018
Q2 | $271M | Buy |
8,277,647
+3,331,009
| +67% | +$100M | 0.09% | 247 |
|
|
2018
Q1 | $135M | Sell |
4,946,638
-102,407
| -2% | -$2.78M | 0.05% | 374 |
|
|
2017
Q4 | $125M | Buy |
5,049,045
+1,286,930
| +34% | +$35.5M | 0.05% | 421 |
|
|
2017
Q3 | $110M | Buy |
3,762,115
+27,175
| +0.7% | +$750K | 0.04% | 465 |
|
|
2017
Q2 | $104M | Buy |
3,734,940
+71,174
| +2% | +$1.89M | 0.03% | 482 |
|
|
2017
Q1 | $91.1M | Sell |
3,663,766
-392,906
| -10% | -$9.55M | 0.03% | 538 |
|
|
2016
Q4 | $87.7M | Sell |
4,056,672
-135,151
| -3% | -$2.95M | 0.03% | 560 |
|
|
2016
Q3 | $99.8M | Sell |
4,191,823
-6,324
| -0.2% | -$151K | 0.03% | 511 |
|
|
2016
Q2 | $98.1M | Sell |
4,198,147
-991,205
| -19% | -$21.4M | 0.04% | 505 |
|
|
2016
Q1 | $97.6M | Buy |
5,189,352
+278,303
| +6% | +$4.89M | 0.04% | 510 |
|
|
2015
Q4 | $90.6M | Buy |
4,911,049
+117,237
| +2% | +$2.1M | 0.04% | 541 |
|
|
2015
Q3 | $78.7M | Sell |
4,793,812
-146,867
| -3% | -$2.51M | 0.03% | 570 |
|
|
2015
Q2 | $87.5M | Buy |
4,940,679
+229,962
| +5% | +$4.11M | 0.03% | 560 |
|
|
2015
Q1 | $83.6M | Buy |
4,710,717
+3,338,842
| +243% | +$52.8M | 0.03% | 575 |
|
|
2014
Q4 | $18.2M | Sell |
1,371,875
-18,451
| -1% | -$236K | 0.01% | 1215 |
|
|
2014
Q3 | $16.4M | Buy |
1,390,326
+162,668
| +13% | +$2.05M | 0.01% | 1268 |
|
|
2014
Q2 | $15.7M | Sell |
1,227,658
-125,378
| -9% | -$1.63M | 0.01% | 1335 |
|
|
2014
Q1 | $18.3M | Sell |
1,353,036
-8,174,510
| -86% | -$107M | 0.01% | 1226 |
|
|
2013
Q4 | $115M | Buy |
9,527,546
+986,283
| +12% | +$11.7M | 0.05% | 460 |
|
|
2013
Q3 | $100M | Buy |
8,541,263
+888,286
| +12% | +$9.61M | 0.04% | 471 |
|
|
2013
Q2 | $70.9M | Buy |
+7,652,977
| New | +$64.9M | 0.03% | 555 |
|
Other funds holding BSX
VCM
VPM
Invesco's BSX Position: Q1 2026 in Review
Invesco reduced its Boston Scientific (BSX) stake by 32% in Q1 2026, selling an estimated $341M and leaving 9,051,941 shares worth $568M. The position accounts for 0.06% of the portfolio, ranked #300.
Invesco first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.81B in Q2 2025. 1,675 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Invesco held 9,051,941 shares of Boston Scientific worth $568M as of Q1 2026.
- Invesco sold 4,266,236 Boston Scientific shares in Q1 2026, an estimated $341M.
- Boston Scientific made up 0.06% of Invesco's portfolio in Q1 2026, its #300 holding.
- Invesco first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Invesco's Boston Scientific position peaked at $1.81B in Q2 2025.
- 1,675 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.